Enhanced cytokine activity Archives - Penn Center for Innovation

CAR T therapy in combination with IL-15R and IL15

February 24, 2026 |

Treatment of cancer by inhibition of Blimp-1 (PRDM1) in the setting of gene-modified T cell therapy

February 24, 2026 |

Chimeric cytokine receptors for enabling adoptive T cell therapy of solid tumors via IL-9 signaling

February 24, 2026 |

Orthogonal cytokine enhanced CAR T cells generated through gene editing

February 24, 2026 |

Potentiating adoptive cell therapy using synthetic IL-9 receptors

February 24, 2026 |

Immunocytokines for specific augmentation of CAR T cells

February 24, 2026 |

Filter